Seminars in Cardiothoracic and Vascular Anesthesia
This journal is a member of the Committee on Publication Ethics (COPE)
Have a question for the editorial office? Contact Benjamin Abrams at the University of Colorado, Aurora, or Miklos Kertai at Vanderbilt University Medical Center, Vanderbilt.
Seminars in Cardiothoracic and Vascular Anesthesia is a quarterly, peer-reviewed publication devoted to the dissemination of educational material involving the cardiovascular and pulmonary systems relevant to the perioperative care of the surgical patient. As of 2017, SCVA expands its scope to transplant anesthesia and critical care, aiming to become a comprehensive academic forum for all physicians involved in thoracic and abdominal organ transplantations.
Presentations feature a multidisciplinary approach with contributions from anesthesiologists, surgeons, internists, specialists in critical care medicine, and other health care practitioners interested in perioperative medicine. Clinical education material centers around topic-based Review Articles, Original Research, Technology Communications, along with case reports and Clinical Challenges which are clinical case based didactic articles. SCVA strives to present internationally relevant subject material and innovative scientific submissions from all continents.
| Benjamin Abrams, MD | University of Colorado, Aurora, CO, USA |
| Miklos D. Kertai, MD, PhD | Vanderbilt University Medical Center, Nashville, TN, USA |
| Ross S. Hanson, MD | University of New Mexico, Albuquerque, NM, USA |
| Jiapeng Huang, MD, PhD, FASA, FASE | University of Louisville, Louisville, KY, USA |
| Jessica Rove, MD | University of Colorado, Aurora, CO, USA |
| Gregory J. Latham, MD | Seattle Children's Hospital and University of Washington Medical Center, Seattle, WA, USA |
| Martin Krauss, MD | University of California San Diego, San Diego, CA, USA |
| Ross S. Hanson, MD | University of New Mexico, Albuquerque, NM, USA |
| Domagoj Mladinov MD, PhD | Brigham and Women's Hospital, Boston, MA, USA |
| Nirvik Pal, MD, MBBS | Virginia Commonwealth University, Richmond, Virginia, USA |
| Tetsuro Sakai, MD, PhD | University of Pittsburgh, Pittsburgh, PA, USA |
| Alex Kaizer, PhD | University of Colorado, Aurora, CO, USA |
| Bryan Ahlgren, DO | University of Colorado, Denver, CO, USA |
| Warwick Aubrey Ames, MBBS, FRCA | Duke University, Durham, NC, USA |
| Jae-Hyon Bahk, MD, MS, PhD | Seoul National University College of Medicine, Seoul, South Korea |
| Mary Beth Brady, MD | Johns Hopkins University, Baltimore, MD, USA |
| Lu Cai, MD, PhD | University of Louisville, Louisville, KY, USA |
| Vladimir Cerny, MD, PhD, FCCM | Charles University in Prague, Czech Republic |
| Albert T. Cheung, MD | University of Pennsylvania, Philadelphia, Pennsylvania, USA |
| Joseph C. Cleveland, Jr., MD | University of Colorado, Denver, CO, USA |
| CDR Chris Cornelissen, MC, USN | Naval Medical Center San Diego, San Diego, CA, USA |
| Brett Cronin, MD | University of California San Diego and VA San Diego Healthcare System, San Diego, California, USA |
| David Daly, MBBS, FANZCA, Grad Cert Clinical Trials | Alfred Hospital, Melbourne, Australia |
| Laurie Davies, MD | University of Florida, Gainesville, FL, USA |
| Dawn Desiderio, MD | Memorial Sloan Kettering Cancer Center, New York, NY, USA |
| James A. DiNardo, MD, FAAP | Harvard Medical School, Boston, MA, USA |
| Steven Edelstein, MD, FASA | Loyola University Medical Center, Maywood, IL, USA |
| Michael Fanshawe, MBBS(Hons I), FAZNCA | Anaesthesiology University of Queensland, Brisbane, Australia |
| David Faraoni, MD, PhD, FAHA | University of Toronto, Sick Kids Research Institute, and The Hospital for Sick Children, Toronto, ON, Canada |
| Bing Feng, MD | Michael E. DeBakey VA Medical Center, Houston, Texas, USA |
| Wei Dong Gao, MD, PhD | Johns Hopkins University, Baltimore, MD, USA |
| Jeremy M. Geiduschek, MD | Seattle Children’s Hospital and University of Washington School of Medicine, Seattle, WA, USA |
| Hilary P. Grocott, MD, FRCPC, FASE | University of Manitoba, Winnipeg, Canada |
| Fabio Guarracino, MD | Azienda Ospedaliero Universitaria Pisana, Pisa, Italy |
| Jacob Gutsche, MD | University of Pennsylvania, Philadelphia, Pennsylvania, USA |
| Nina A. Guzzetta, MD | Children's Healthcare of Atlanta, Atlanta, GA, USA |
| Nazish Hashmi, MD | Duke University, Durham, NC, USA |
| Kevin W. Hatton, MD | University of Kentucky, Lexington, KY, USA |
| Eugene A. Hessel | University of Kentucky, Lexington, Kentucky, USA |
| Thomas L. Higgins, MD, MBA, FAC,P MCCM, FAAPL | The Center For Case Management, Natick, MA, USA |
| Nian Chih Hwang, MBBS, FFARCSI, FAMS, GDAcu | Singapore General Hospital, Singapore |
| Richard J. Ing, MB, BCh, FCA(SA) | University of Colorado, Denver, CO, USA |
| Gregory M. Janelle, MD | University of Florida, Gainesville, FL, USA |
| Justin Sangwook Ko, MD, PhD | Sungkyunkwan University and Samsung Medical Center, Seoul, Korea |
| Barry D. Kussman, MBBCh, FFA(SA) | Harvard Medical School, Boston, MA, USA |
| Geoffrey Lighthall, MD, PhD | Stanford University School of Medicine, Stanford, California, USA |
| Frederick W. Lombard, MBChB, FANZCA | Vanderbilt University Medical Center, Nashville, TN, USA |
| Michael W. Manning, MD, PhD | Duke University, Durham, NC, USA |
| Timothy Maus, MD, FASE | University of California San Diego, La Jolla, California, USA |
| Stuart A. McCluskey, MD, PhD, FRCPC | University Health Network, Toronto, ON, Canada |
| John D. Mitchell, MD | University of Colorado, Denver, CO, USA |
| Mona Momeni, MD, PhD | UCLouvain, Ottignies-Louvain-la-Neuve, Belgium |
| Tjorvi E. Perry, MD, MMSc | University of Minnesota, Minneapolis, MN, USA |
| Ernesto A. Pretto, Jr., MD, MPH | University of Miami and Jackson Memorial Hospital, Miami, FL, USA |
| George Silvay,MD, PhD | Icahn School of Medicine at Mount Sinai, New York, New York, USA |
| Mark S. Slaughter, MD | University of Louisville, Louisville, KY, USA |
| Alan Smeltz | University of North Carolina at Chapel Hill Hospital, Chapel Hill, NC, USA |
| Kathirvel Subramaniam, MD, MPH, FASE | University of Pittsburgh, Pittsburgh, PA, USA |
| Kenichi Tanaka, MD, MSc | University of Maryland, Baltimore, MD, USA |
| Deepak Tempe, MD | Maulana Azad Medical College, New Delhi, India |
| Lian Kah Ti, MBBS, MMed, FAMS | National University Health System, Singapore |
| Mark D. Twite, MD | The Children's Hospital and University of Colorado, Denver, CO, USA |
| David F. Vener, MD | Houston, USA |
| Luigi Vetrugno, MD | University of Udine, Udine, Italy |
| Joseph Woo, MD | Stanford University, Stanford, CA, USA |
| Rick Sai-chuen Wu, MD | China Medical University Hospital, Taichung City, Taiwan |
| Jeron Zerillo, MD | Mount Sinai Health System, New York, NY, USA |
This Journal is a member of the Committee on Publication Ethics.
This Journal recommends that authors follow the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals formulated by the International Committee of Medical Journal Editors (ICMJE).
Please read the guidelines below then visit Seminars in Cardiothoracic and Vascular Anesthesia (SCVA)'s submission site to upload your manuscript. Please note that manuscripts not conforming to these guidelines may be returned. Remember you can log in to the submission site at any time to check on the progress of your paper through the peer review process.
SAGE Publishing disseminates high-quality research and engaged scholarship globally, and we are committed to diversity and inclusion in publishing. We encourage submissions from a diverse range of authors from across all countries and backgrounds.
Only manuscripts of sufficient quality that meet the aims and scope of SCVA will be reviewed.
There are no fees payable to submit or publish in this journal.
As part of the submission process you will be required to warrant that you are submitting your original work, that you have the rights in the work, and that you have obtained and can supply all necessary permissions for the reproduction of any copyright works not owned by you, that you are submitting the work for first publication in the Journal and that it is not being considered for publication elsewhere and has not already been published elsewhere. Please see our guidelines on prior publication and note that SCVA may accept submissions of papers that have been posted on pre-print servers; please alert the Editorial Office when submitting (contact details are at the end of these guidelines) and include the DOI for the preprint in the designated field in the manuscript submission system. Authors should not post an updated version of their paper on the preprint server while it is being peer reviewed for possible publication in the journal. If the article is accepted for publication, the author may re-use their work according to the journal's author archiving policy. If your paper is accepted, you must include a link on your preprint to the final version of your paper.
If you have any questions about publishing with SAGE, please visit the SAGE Journal Solutions Portal.
1. What do we publish?
1.1 Aims & Scope
1.2 Article types
1.3 Writing your paper
2. Editorial policies
2.1 Peer review policy
2.2 Authorship
2.3 Acknowledgements
2.4 Funding
2.5 Declaration of conflicting interests
2.6 Research ethics and patient consent
2.7 Clinical trials
2.8 Reporting guidelines
2.9 Research Data
3. Publishing polices
3.1 Publication ethics
3.2 Contributor’s publishing agreement
3.3 Open access and author archiving
4. Preparing your manuscript
4.1 Formatting
4.2 Artwork, figures and other graphics
4.3 Supplemental material
4.4 Reference style
4.5 English language editing services
5. Submitting your manuscript
5.1 ORCID
5.2 Information required for completing your submission
5.3 Permissions
6. On acceptance and publication
6.1 SAGE Production
6.2 Online First publication
6.3 Access to your published article
6.4 Promoting your article
1.1 Aims & Scope
Seminars in Cardiothoracic and Vascular Anesthesia is a quarterly, peer-reviewed that serves the educational needs of clinicians practicing cardiac, thoracic, and vascular anesthesia and related specialties. It fulfills an important niche as one of only two journals devoted to the anesthetic and perioperative care of patients with heart, lung, and vascular disease.
1.2 Article types
Upon submission, provide a title page that includes all contributing authors and their affiliations. Please select the correct file type designation when uploading your title page, manuscript, supplementary files, etc.
Please cite relevant SCVA articles whenever possible.
Clinical Challenges
Clinical Challenges are a report that describes a clinically challenging case, but focuses on the clinical decision making process in an educational / didactic format. Roughly ¼ to 1/3 of the article can be devoted to the case description, with the majority of the manuscript focused on key didactic points relevant to the case. The word count for these reports should be 1500 – 3000 words. This type of manuscript should include relevant clinical imaging. This manuscript can include echocardiography rounds if it meets the above criteria, and should include 2-3 movie clips of the imaging findings as well as associated still image clips. Please use MP4, MOV, or WMV files and preview the clips to make sure they are visible on both Windows and Macintosh platforms. Still images should be in high resolution JPEG or TIFF files. Please format the movies in at least 480 x 360 pixels or 640 x 480. Limit clips to 20 seconds.
Narrative Reviews
Narrative Reviews should consist of 2000-6000 words, and can include a 20-50 reference limit. A maximum of 4 tables and 4 figures are permitted. Co-authorship with up to four colleagues is acceptable.
Review Articles
Review Articles should be written for a targeted length of 4000-6000 words, and can include a wide range of references (typically 30-80). These articles are either by invitation, or open to free submission. Please contact the Editors, Miklos D. Kertai and Benjamin Abrams, if you are interested in writing a review and provide a proposed topic and timeline for submission. Please look through the existing review database on the SCVA website for previous topic coverage to avoid repeating any recently reviewed items. Tables, Figures, and clinical imaging are encouraged as part of these manuscripts.
1.3 Writing your paper
The SAGE Author Gateway has some general advice and on how to get published, plus links to further resources. SAGE Author Services also offers authors a variety of ways to improve and enhance their article including English language editing, plagiarism detection, and video abstract and infographic preparation.
1.3.1 Make your article discoverable
When writing up your paper, think about how you can make it discoverable. The title, keywords and abstract are key to ensuring readers find your article through search engines such as Google. For information and guidance on how best to title your article, write your abstract and select your keywords, have a look at this page on the Gateway: How to Help Readers Find Your Article Online
2.1 Peer review policy
SCVA adheres to a rigorous double-anonymized reviewing policy in which the identity of both the reviewer and author are always concealed from both parties.
As part of the submission process you will be asked to provide the names of 2 peers who could be called upon to review your manuscript. Two reviewers must complete reviews for each manuscript before a decision is reached. Recommended reviewers should be experts in their fields and should be able to provide an objective assessment of the manuscript. Please be aware of any conflicts of interest when recommending reviewers. Examples of conflicts of interest include (but are not limited to) the below:
- The reviewer should have no prior knowledge of your submission
- The reviewer should not have recently collaborated with any of the authors
- Reviewer nominees from the same institution as any of the authors are not permitted
You will also be asked to nominate peers who you do not wish to review your manuscript (opposed reviewers).
SCVA is committed to delivering high quality, fast peer-review for your paper, and as such has partnered with Publons. Publons is a third party service that seeks to track, verify and give credit for peer review. Reviewers for the journal can opt in to Publons in order to claim their reviews or have them automatically verified and added to their reviewer profile. Reviewers claiming credit for their review will be associated with the relevant journal, but the article name, reviewer’s decision and the content of their review is not published on the site. For more information visit the Publons website.
2.2 Authorship
Papers should only be submitted for consideration once consent is given by all contributing authors. Those submitting papers should carefully check that all those whose work contributed to the paper are acknowledged as contributing authors.
The list of authors should include all those who can legitimately claim authorship. This is all those who:
(i) Made a substantial contribution to the concept or design of the work; or acquisition, analysis or interpretation of data,
(ii) Drafted the article or revised it critically for important intellectual content,
(iii) Approved the version to be published,
(iv) Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content.
Authors should meet the conditions of all of the points above. When a large, multicentre group has conducted the work, the group should identify the individuals who accept direct responsibility for the manuscript. These individuals should fully meet the criteria for authorship.
Acquisition of funding, collection of data, or general supervision of the research group alone does not constitute authorship, although all contributors who do not meet the criteria for authorship should be listed in the Acknowledgments section. Please refer to the International Committee of Medical Journal Editors (ICMJE) authorship guidelines for more information on authorship.
2.3 Acknowledgements
All contributors who do not meet the criteria for authorship should be listed in an Acknowledgements section. Examples of those who might be acknowledged include a person who provided purely technical help, or a department chair who provided only general support.
Upon submission, you will be asked to confirm that if any content is AI-generated, it is clearly identified within the text and acknowledged within your Acknowledgements section. Please note that AI bots such as ChatGPT should not be listed as an author. For more details on this policy, please visit this page.
Please supply any personal acknowledgements separately to the main text to facilitate anonymous peer review.
2.3.1 Third party submissions
Where an individual who is not listed as an author submits a manuscript on behalf of the author(s), a statement must be included in the Acknowledgements section of the manuscript and in the accompanying cover letter. The statements must:
- Disclose this type of editorial assistance – including the individual’s name, company and level of input
- Identify any entities that paid for this assistance
- Confirm that the listed authors have authorized the submission of their manuscript via third party and approved any statements or declarations, e.g. conflicting interests, funding, etc.
Where appropriate, SAGE reserves the right to deny consideration to manuscripts submitted by a third party rather than by the authors themselves.
2.3.2 Writing assistance
Individuals who provided writing assistance, e.g. from a specialist communications company, do not qualify as authors and so should be included in the Acknowledgements section. Authors must disclose any writing assistance – including the individual’s name, company and level of input – and identify the entity that paid for this assistance. It is not necessary to disclose use of language polishing services.
2.4 Funding
SCVA requires all authors to acknowledge their funding in a consistent fashion under a separate heading. Please visit the Funding Acknowledgements page on the SAGE Journal Author Gateway to confirm the format of the acknowledgment text in the event of funding, or state that: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
2.5 Declaration of conflicting interests
It is the policy of SCVA to require a declaration of conflicting interests from all authors enabling a statement to be carried within the paginated pages of all published articles.
Please ensure that a ‘Declaration of Conflicting Interests’ statement is included at the end of your manuscript, after any acknowledgements and prior to the references. If no conflict exists, please state that ‘The Author(s) declare(s) that there is no conflict of interest’. For guidance on conflict of interest statements, please see the ICMJE recommendations here
2.6 Research ethics and patient consent
Medical research involving human subjects must be conducted according to the World Medical Association Declaration of Helsinki
Submitted manuscripts should conform to the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, and all papers reporting animal and/or human studies must state in the methods section that the relevant Ethics Committee or Institutional Review Board provided (or waived) approval. Please ensure that you have provided the full name and institution of the review committee, in addition to the approval number.
For research articles, authors are also required to state in the methods section whether participants provided informed consent and whether the consent was written or verbal.
Information on informed consent to report individual cases or case series must be included in the manuscript text. A statement is required confirming that informed consent for patient information and images to be published was provided by the patient(s) or a legally authorized representative.
Please also refer to the ICMJE Recommendations for the Protection of Research Participants
All research involving animals submitted for publication must be approved by an ethics committee with oversight of the facility in which the studies were conducted. The Journal has adopted the ARRIVE guidelines.
2.7 Clinical trials
SCVA conforms to the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first patient enrolment as a condition of consideration for publication. The trial registry name and URL, and registration number must be included at the end of the abstract.
2.8 Reporting guidelines
The relevant EQUATOR Network reporting guidelines should be followed depending on the type of study. For example, all randomized controlled trials submitted for publication should include a completed CONSORT flow chart as a cited figure and the completed CONSORT checklist should be uploaded with your submission as a supplementary file. Systematic reviews and meta-analyses should include the completed PRISMA flow chart as a cited figure and the completed PRISMA checklist should be uploaded with your submission as a supplementary file. The EQUATOR wizard can help you identify the appropriate guideline.
Other resources can be found at NLM’s Research Reporting Guidelines and Initiatives
2.9 Research Data
The journal is committed to facilitating openness, transparency and reproducibility of research, and has the following research data sharing policy. For more information, including FAQs please visit the SAGE Research Data policy pages.
Subject to appropriate ethical and legal considerations, authors are encouraged to:
- share your research data in a relevant public data repository
- include a data availability statement linking to your data. If it is not possible to share your data, we encourage you to consider using the statement to explain why it cannot be shared.
- cite this data in your research
For further information, please contact the editorial office at katie.willis@sagepub.com.
3.1 Publication ethics
SAGE is committed to upholding the integrity of the academic record. We encourage authors to refer to the Committee on Publication Ethics’ International Standards for Authors and view the Publication Ethics page on the SAGE Author Gateway
3.1.1 Plagiarism
SCVA and SAGE take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. We seek to protect the rights of our authors and we always investigate claims of plagiarism or misuse of published articles. Equally, we seek to protect the reputation of the journal against malpractice. Submitted articles may be checked with duplication-checking software. Where an article, for example, is found to have plagiarised other work or included third-party copyright material without permission or with insufficient acknowledgement, or where the authorship of the article is contested, we reserve the right to take action including, but not limited to: publishing an erratum or corrigendum (correction); retracting the article; taking up the matter with the head of department or dean of the author's institution and/or relevant academic bodies or societies; or taking appropriate legal action.
3.1.2 Prior publication
If material has been previously published it is not generally acceptable for publication in a SAGE journal. However, there are certain circumstances where previously published material can be considered for publication. Please refer to the guidance on the SAGE Author Gateway or if in doubt, contact the Editor at the address given below.
3.2 Contributor’s publishing agreement
Before publication, SAGE requires the author as the rights holder to sign a Journal Contributor’s Publishing Agreement. SAGE’s Journal Contributor’s Publishing Agreement is an exclusive licence agreement which means that the author retains copyright in the work but grants SAGE the sole and exclusive right and licence to publish for the full legal term of copyright. Exceptions may exist where an assignment of copyright is required or preferred by a proprietor other than SAGE. In this case copyright in the work will be assigned from the author to the society. For more information please visit the SAGE Author Gateway
3.3 Open access and author archiving
SCVA offers optional open access publishing via the SAGE Choice programme. For more information on Open Access publishing options at SAGE please visit SAGE Open Access. For information on funding body compliance, and depositing your article in repositories, please visit SAGE’s Author Archiving and Re-Use Guidelines and Publishing Policies.
4. Preparing your manuscript for submission
4.1 Formatting
The preferred format for your manuscript is Word. LaTeX files are also accepted. Word and (La)Tex templates are available on the Manuscript Submission Guidelines page of our Author Gateway.
4.2 Artwork, figures and other graphics
For guidance on the preparation of illustrations, pictures and graphs in electronic format, please visit SAGE’s Manuscript Submission Guidelines
Figures supplied in colour will appear in colour online regardless of whether or not these illustrations are reproduced in colour in the printed version. For specifically requested colour reproduction in print, you will receive information regarding the costs from SAGE after receipt of your accepted article.
4.3 Supplemental material
This journal is able to host additional materials online (e.g. datasets, podcasts, videos, images etc.) alongside the full-text of the article. For more information please refer to our guidelines on submitting supplemental files
4.4 Reference style
SCVA adheres to the AMA reference style. View the AMA guidelines to ensure your manuscript conforms to this reference style.
4.5 English language editing services
Authors seeking assistance with English language editing, translation, or figure and manuscript formatting to fit the journal’s specifications should consider using SAGE Language Services. Visit SAGE Language Services on our Journal Author Gateway for further information.
SCVA is hosted on SAGE Track, a web based online submission and peer review system powered by ScholarOne™ Manuscripts. Visit https://mc.manuscriptcentral.com/scva to login and submit your article online.
IMPORTANT: Please check whether you already have an account in the system before trying to create a new one. If you have reviewed or authored for the journal in the past year it is likely that you will have had an account created. For further guidance on submitting your manuscript online please visit ScholarOne Online Help.
5.1 ORCID
As part of our commitment to ensuring an ethical, transparent and fair peer review process SAGE has become a supporting member of ORCID, the Open Researcher and Contributor ID. ORCID provides a unique and persistent digital identifier that distinguishes researchers from every other researcher, even those who share the same name, and, through integration in key research workflows such as manuscript and grant submission, supports automated linkages between researchers and their professional activities, ensuring that their work is recognized.
The collection of ORCID iDs from corresponding authors is now part of the submission process of this journal. If you already have an ORCID iD you will be asked to associate that to your submission during the online submission process. We also strongly encourage all co-authors to link their ORCID ID to their accounts in our online peer review platforms. It takes seconds to do: click the link when prompted, sign into your ORCID account and our systems are automatically updated. Your ORCID iD will become part of your accepted publication’s metadata, making your work attributable to you and only you. Your ORCID iD is published with your article so that fellow researchers reading your work can link to your ORCID profile and from there link to your other publications.
If you do not already have an ORCID iD please follow this link to create one or visit our ORCID homepage to learn more.
5.2 Information required for completing your submission
You will be asked to provide contact details and academic affiliations for all co-authors via the submission system and identify who is to be the corresponding author. These details must match what appears on your manuscript. The affiliation listed in the manuscript should be the institution where the research was conducted. If an author has moved to a new institution since completing the research, the new affiliation can be included in a manuscript note at the end of the paper. At this stage please ensure you have included all the required statements and declarations and uploaded any additional supplementary files (including reporting guidelines where relevant).
5.3 Permissions
Please also ensure that you have obtained any necessary permission from copyright holders for reproducing any illustrations, tables, figures or lengthy quotations previously published elsewhere. For further information including guidance on fair dealing for criticism and review, please see the Copyright and Permissions page on the SAGE Author Gateway
6. On acceptance and publication
6.1 SAGE Production
Your SAGE Production Editor will keep you informed as to your article’s progress throughout the production process. Proofs will be made available to the corresponding author via our editing portal SAGE Edit or by email, and corrections should be made directly or notified to us promptly. Authors are reminded to check their proofs carefully to confirm that all author information, including names, affiliations, sequence and contact details are correct, and that Funding and Conflict of Interest statements, if any, are accurate.
6.2 Online First publication
Online First allows final articles (completed and approved articles awaiting assignment to a future issue) to be published online prior to their inclusion in a journal issue, which significantly reduces the lead time between submission and publication. Visit the SAGE Journals help page for more details, including how to cite Online First articles.
6.3 Access to your published article
SAGE provides authors with online access to their final article.
6.4 Promoting your article
Publication is not the end of the process! You can help disseminate your paper and ensure it is as widely read and cited as possible. The SAGE Author Gateway has numerous resources to help you promote your work. Visit the Promote Your Article page on the Gateway for tips and advice.
Follow and tag @SCVA1997 and @SAGEClinMed on Twitter to promote your paper and stay up-to-date on the latest news from the journal.
Any correspondence, queries or additional requests for information on the manuscript submission process should be sent to the SCVA editorial office as follows:
Editor-in-Chief, Benjamin Abrams benjamin.abrams@cuanschutz.edu
Editor-in-Chief, Miklos Kertai miklos.kertai@vumc.org